An innovative NIMH-funded trial shows that a receptor involved in the brain’s reward system may be a viable target for treating anhedonia (or lack of pleasure), a key symptom of several mood and anxiety disorders.
Source: NIH
Science News » Fast-Fail Trial Shows New Approach to Identifying Brain Targets for Clinical Treatments
Published in Psychiatric
More from PsychiatricMore posts in Psychiatric »
- Extramural Research Community Listening Session: Town Hall
- Understanding Psychology's Integrative Themes: Introduction
- The NIMH Director’s Innovation Speaker Series: Addressing Social Determinants to Optimize Infant Brain Development
- Director’s Innovation Speaker Series: Addressing Social Determinants to Optimize Infant Brain Development
- Is it time to rename schizophrenia?